• The submitting author must be the first (presenting) author.
• An individual may only submit one abstract and can be the presenting author of only one abstract, including speakers in Featured Symposia.
• There is no limit to the number of times an individual may appear as co-author on abstracts.
• Co-authors do not receive communication related to the abstract. First (presenting) authors are responsible for coordinating communication with co-authors. First (presenting) authors must notify all authors of all correspondence relating to this abstract submission and confirm that each co-author has been informed of the abstract submission and has agreed to all information as it was submitted.
• Submitting authors must intend to attend the Annual Meeting in person with the understanding that ASHG is not making any commitments to host virtual or hybrid content formats and reserves the right, at its sole discretion, to adjust presentation format and style. Submitting authors of accepted abstracts must acknowledge acceptance and purchase a scientific meeting registration by September 9, 5pm ET.
• If substitution of the first (presenting) author becomes necessary, you must inform ASHG by completing the Presenter Change Request Form by September 9, 5pm ET. Substitution is not allowed without prior written approval.
• Authors who fail to notify ASHG that they cannot attend may not be invited to present at future meetings.
• Duplicate abstracts are not permitted regardless of changes in author order. Abstracts suspected to be duplicates may be rejected during the review process.
• By submitting an abstract, the submitting author consents to ASHG sending communications about its Annual Meeting, including the status of the abstract.
• Presenting authors of oral presentations must include a conflict-of-interest slide as part of the presentation and provide verbal and written disclosures to attendees.
• Presenting authors of oral presentations must use generic names (i.e., non-branded names) in the presentation as much as possible. Presentations can neither promote nor disparage specific products of ineligible companies. Presentations cannot contain advertisements for a specific product, company, and/or service nor contain any logos of an ineligible company. Presenters must disclose on the required disclosure slide any unlabeled/unapproved uses of drugs or products referenced in the presentation/materials.

• Tracks are used to categorize the focus of the session. Submitters must choose one of the following tracks that best fits their abstract: Basic or Translational Research; Clinical Research; Diversity, Equity, and Inclusion; Ethical, Legal, and Social Implications; Teaching or Education.
• Topics allow the Program Committee to accurately review abstract submissions. Submitters must choose one main topic that best fits their abstract from the provided list of topics.
• Keywords aid in the review process and help attendees decide which sessions are relevant to their interests. Submitters must choose at least one, but no more than five, keywords from the provided list of keywords.
• Primary audience is used to assist in tagging programmed abstracts to help attendees find suitable sessions for their interests. Submitters must choose one of the following primary audiences for their abstract: Clinicians; Educators; Genetic Counselors; Researchers; Trainees.

A major goal of the ASHG Annual Meeting is to showcase leading-edge research that is new to the field and appears in an international forum for the first time. If the findings in this abstract submission have been or will be published elsewhere prior to June 9, 2025, authors should make clear what new information will be presented.

• It is the author’s responsibility to update the submission concerning any acceptances that occur before the submission deadline of June 9.
• For abstracts that are previously published, authors are strongly encouraged to describe any advancement beyond published work that will be presented.
• At time of assigning platform talks, the Program Committee will independently verify whether there is a publication available with an acceptance date before June 9. Failure to disclose prior publication will result in abstracts being deprioritized for oral presentation in plenary or platform sessions.

For purposes of this policy, “previously published” means:

1. Accepted for peer-reviewed publication, or
2. Accepted for oral presentation at other conferences.

Material posted on a preprint server is NOT considered previously published.

• All submitters must confirm that any reported human participants research was conducted with participants’ voluntary, informed consent, with approval by an appropriate research ethics committee, and consistent with the principles of research ethics. ASHG endorses the protections embodied in the principles of the Declaration of Helsinki and the Belmont Report, and their expansion in the regulations governing research supported by the U.S. Government (45 CFR Part 46).
• All submitters must confirm that investigations involving animals reported in the abstract must have been conducted in accordance with the FASEB Statement of Principles for the use of Animals in Research and Education.
• ASHG does not endorse and will not publish the results of research that was not conducted in accordance with these principles.

Accepted abstracts will be available in mid-September in the Online Planner. At this time, your abstract and all information will become a matter of public record and may be referenced by ASHG, media relations staff, and others.

Please see our Licensing Agreement/Copyright Policy and suggested style for citing ASHG Meeting abstracts on this webpage.

ASHG aims to encourage presentation of the latest findings and enable responsible and quality reporting of those findings by press in attendance. Though the press may contact authors prior to the presentation for more information, any resulting articles or other press items cannot be released until the work is presented at the meeting.

General rules to follow:

• Abstract title and author names: Can be released at any time.
• Abstract text: Can only be released after the meeting program (with the abstract text) is made public. Linking to the abstract text on the ASHG website is suggested.
• Findings outlined in the abstract (whether a poster or oral presentation): Can only be released after the presentation has occurred.

If you have any questions about this, please contact press@ashg.org.

Submitting authors must agree to the conditions of the Submission Guidelines and Policies. Failure to meet these conditions may result in abstract withdrawal and the opportunity to present at the Annual Meeting forfeited.

After the June 9 deadline, abstracts will be reviewed by the Program Committee (PC), plus three independent reviewers for each topic category.

The committee programs abstracts as follows:

• Topic categories selected by abstract submitters may be reassigned during review if the abstract content does not appear to match the topic selected in order to ensure appropriate expert review.
• Each reviewer scores the abstracts independently using this rubric, without knowledge of the name(s) and institution(s) of the submitter(s) or the scores given by the other reviewers.
• In July, the PC meets to assign abstracts to plenary, platform, lightning talk, and poster sessions based on each abstract’s cumulative score as well as the impact of the science and the balance of topics for ASHG’s multi-disciplinary audience.
  • 15 of the top-scoring abstracts are selected for plenary sessions.
  • 248 abstracts are selected for platform sessions.
  • The remaining accepted abstracts are assigned to posters.
    • The top-scoring poster abstracts are awarded the Reviewers’ Choice designation and, of those, at least 60 are selected for lightning talks.
• The PC reserves the right to decline abstracts that lack scientific content or merit, lack human genetics and genomics research and/or data, or that merely announce the availability of a resource or service and are primarily promotional.
• Abstract acceptance notifications will be sent to authors in early August.